Let's Be More Sensitive-How SGLT-2 Inhibitors and GLP-1 Receptor Agonists Affect beta-Cell Function in Type 2 Diabetes Comment on "Improved Beta Cell Glucose Sensitivity Plays Predominant Role in the Decrease in HbA1c with Cana and Lira in T2DM" by Ali et al
Editorial Material